Neuroprotective role of lipoic acid against acute toxicity of N-acetylaspartic acid

Molecular and Cellular Biochemistry

Volumn 344, Issue 1-2, 2010, Pages 231-239

  Pederzolli, Carolina Didonet ^a   Rosa, Andrea Pereira ^a   De Oliveira, Amanda Szekir ^a   Coelho, Juliana G ^a   Da Luz Becker, Débora ^a   Dalazen, Giovana Reche ^a   Moraes, Tarsila Barros ^a   Dutra Filho, Carlos S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antioxidant; Canavan disease; Lipoic acid; N Acetylaspartic acid; Neuroprotection; Oxidative stress

Indexed keywords

CARBONYL DERIVATIVE; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; N ACETYLASPARTIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS LINKING; IN VITRO STUDY; IN VIVO STUDY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RAT;

ANIMALS; ASPARTIC ACID; CATALASE; GLUTATHIONE PEROXIDASE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOCTIC ACID;

RATTUS; RATTUS NORVEGICUS;

EID: 78449287697     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0547-x     Document Type: Article

References (57)

1. Halliwell B, Gutteridge JMC (2007) The chemistry of free radicals and related 'reactive species'. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press, Oxford, pp 37-104
2. L Packer EH Witt HJ Tritschler 1995 Alpha-lipoic acid as a biological antioxidant Free Radic Biol Med 19 227 250 1:CAS:528:DyaK2MXmsFKntbc%3D 10.1016/0891-5849(95)00017-R 7649494
3. GP Biewenga GR Haenen A Bast 1997 The pharmacology of the antioxidant lipoic acid Gen Pharmacol 29 315 331 1:CAS:528:DyaK2sXls1OlsLc%3D 9378235
4. A Bast GR Haenen 2003 Lipoic acid: a multifunctional antioxidant Biofactors 17 207 213 1:CAS:528:DC%2BD3sXlsl2rtr4%3D 10.1002/biof.5520170120 12897442
5. L Packer HJ Tritschler K Wessel 1997 Neuroprotection by the metabolic antioxidant alpha-lipoic acid Free Radic Biol Med 22 359 378 1:CAS:528:DyaK28XnsVGisr0%3D 10.1016/S0891-5849(96)00269-9 8958163
6. S Samuel R Kathirvel T Jayavelu P Chinnakkannu 2005 Protein oxidative damage in arsenic induced rat brain: influence of dl-α-lipoic acid Toxicol Lett 155 27 34 1:CAS:528:DC%2BD2cXhtVCktrrJ 10.1016/j.toxlet.2004.08.001 15585356
7. S Roy CK Sen HJ Tritschler L Packer 1997 Modulation of cellular reducing equivalent homeostasis by alpha-lipoic acid. Mechanisms and implications for diabetes and ischemic injury Biochem Pharmacol 53 393 399 1:CAS:528: DyaK2sXhs1Gnsrs%3D 10.1016/S0006-2952(96)00764-2 9065743
8. D Ziegler M Reljanovic H Mehnert FA Gries 1999 Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials Exp Clin Endocrinol Diabetes 107 421 430 1:CAS:528:DyaK1MXnsF2rtbg%3D 10.1055/s-0029-1212132 10595592
9. P Arivazhagan C Panneerselvam 2000 Effect of dl-alpha-lipoic acid on neural antioxidants in aged rats Pharmacol Res 42 219 222 1:CAS:528: DC%2BD3cXls12rtrg%3D 10.1006/phrs.2000.0679 10945926
10. FA Hommes HA Polman AD Patrick 1968 Leigh's encephalomyelopathy: an inborn error of gluconeogenesis Arch Dis Child 43 423 426 1:STN:280: DyaF1czisFOrtQ%3D%3D 10.1136/adc.43.230.423 4873809
11. Blass J (1983) Inborn errors of pyruvate metabolism. In: Stanbury J, Wyngaarden J, Fredrickson DS, Goldstein J, Brown M (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 193-203
12. R Matalon DA Stumpf K Michals RD Hart JK Parks SI Goodman 1984 Lipoamide dehydrogenase deficiency with primary lactic acidosis: favorable response to treatment with oral lipoic acid J Pediatr 104 65 69 1:STN:280: DyaL2c%2FovFyntg%3D%3D 10.1016/S0022-3476(84)80591-0 6418873
13. EC Traeger I Rapin 1998 The clinical course of Canavan disease Pediatr Neurol 18 207 212 1:STN:280:DyaK1c3islyksg%3D%3D 10.1016/S0887-8994(97)00185-9 9568915
14. R Matalon K Michals-Matalon 2000 Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings Front Biosci 5 d307 d311 1:CAS:528:DC%2BD3cXht1Sht70%3D 10.2741/Matalon 10704428
15. Beaudet A (2001) Aspartoacylase deficiency (Canavan disease). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 5799-5805
16. CN Madhavarao P Arun JR Moffett S Szucs S Surendran R Matalon J Garbern D Hristova A Johnson W Jiang MAA Namboodiri 2005 Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease Proc Natl Acad Sci USA 102 5221 5226 1:CAS:528:DC%2BD2MXjsFemtbc%3D 10.1073/pnas.0409184102 15784740
17. S Kumar NS Mattan J de Vellis 2006 Canavan disease: a white matter disorder Ment Retard Dev Disabil Res Rev 12 157 165 10.1002/mrdd.20108 16807907
18. SG Srikanth HS Chandrashekar K Nagarajan PN Jayakumar 2007 Restricted diffusion in Canavan disease Childs Nerv Syst 23 465 468 1:STN:280: DC%2BD2s7ktVyrsg%3D%3D 10.1007/s00381-006-0238-9 17219235
19. M Adachi J Torii L Schneck BW Volk 1972 Electron microscopy and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrand type) Acta Neuropathol (Berl) 20 22 1:STN:280:DyaE387msFCnug%3D%3D 10.1007/BF00687899
20. CG Janson SWJ McPhee J Francis D Shera M Assadi A Freese P Hurh J Haselgrove DJ Wang L Bilaniuk P Leone 2006 Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI Neuropediatrics 37 209 221 1:CAS:528:DC%2BD2sXitVCmtb8%3D 10.1055/s-2006-924734 17177147
21. Y Rubin MC LaPlaca DH Smith LE Thibault RE Lenkinski 1995 The effect of N-acetylaspartate on the intracellular free calcium concentration in NTera2-neurons Neurosci Lett 198 209 212 1:CAS:528:DyaK2MXoslGlu7w%3D 10.1016/0304-3940(95)12014-U 8552323
22. T Akimitsu K Kurisu R Hanaya K Iida Y Kiura K Arita H Matsubayashi K Ishihara K Kitada T Serikawa M Sasa 2000 Epileptic seizures induced by N-aspartate in rats: in vivo and in vitro studies Brain Res 861 143 150 1:CAS:528:DC%2BD3cXit1Whsb0%3D 10.1016/S0006-8993(00)02028-X 10751574
23. K Kitada T Akimitsu Y Shigematsu A Kondo T Maihara N Yokoi T Kuramoto M Sasa T Serikawa 2000 Accumulation of N-acetylaspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system J Neurochem 74 2512 2519 1:CAS:528: DC%2BD3cXjsVKrsL8%3D 10.1046/j.1471-4159.2000.0742512.x 10820213
24. HD Yan K Ishihara T Serikawa M Sasa 2003 Activation by N-acetyl-l-aspartate of acutely dissociated hippocampal neurons in rats via metabotropic glutamate receptors Epilepsia 44 1153 1159 1:CAS:528: DC%2BD3sXnvF2murc%3D 10.1046/j.1528-1157.2003.49402.x 12919386
25. M Klugmann CB Leichtlein C Wymond Symes T Serikawa D Young MJ During 2005 Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease Mol Ther 11 745 753 1:CAS:528:DC%2BD2MXjsFGqsbk%3D 10.1016/j.ymthe.2005.01.006 15851013
26. CD Pederzolli CP Mescka F Scapin FJ Rockenbach AM Sgaravatti MB Sgarbi ATS Wyse CMD Wannmacher M Wajner CS Dutra-Filho 2007 N-Acetylaspartic acid promotes oxidative stress in cerebral cortex of rats Int J Dev Neurosci 25 317 324 1:CAS:528:DC%2BD2sXotVans70%3D 10.1016/j.ijdevneu.2007.04.002 17604935
27. CD Pederzolli FJ Rockenbach FR Zanin NT Henn EC Romagna AM Sgaravatti AT Wyse CM Wannmacher M Wajner A de Mattos Dutra CS Dutra-Filho 2009 Intracerebroventricular administration of N-acetylaspartic acid impairs antioxidant defenses and promotes protein oxidation in cerebral cortex of rats Metab Brain Dis 24 283 298 1:CAS:528:DC%2BD1MXlvV2itLw%3D 10.1007/s11011-009- 9137-6 19294497
28. SF Llesuy J Milei H Molina 1985 Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4′-epiadriamycin in mice Tumori 71 241 249 1:CAS:528:DyaL2MXkvFynsLw%3D 3861023
29. E Lissi T Caceres LA Videla 1986 Visible chemiluminescence from rat brain homogenates undergoing autoxidation. I. Effect of additives and products accumulation Free Radic Biol Med 2 63 69 1:CAS:528:DyaL28XmtVCrt7c%3D
30. H Aebi 1984 Catalase in vitro Methods Enzymol 105 121 126 1:CAS:528:DyaL2cXltVKis7s%3D 10.1016/S0076-6879(84)05016-3 6727660
31. A Wendel 1981 Glutathione peroxidase Methods Enzymol 77 325 332 1:CAS:528:DyaL38XhtFOrur0%3D 10.1016/S0076-6879(81)77046-0 7329310
32. E Pick Y Keisari 1980 A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture J Immunol Methods 38 161 170 1:CAS:528:DyaL3MXnvFKhtg%3D%3D 10.1016/0022-1759(80)90340-3 6778929
33. H Ohkawa N Ohishi K Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 351 358 1:CAS:528: DyaE1MXksFaisbk%3D 10.1016/0003-2697(79)90738-3 36810
34. ER Stadtman 1990 Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences Free Radic Biol Med 9 315 325 1:CAS:528:DyaK3MXltVylsLY%3D 10.1016/0891-5849(90)90006-5 2283087
35. ER Stadtman RL Levine 2003 Free-radical mediated oxidation of free amino acids and amino acid residues in proteins Amino Acids 25 207 218 1:CAS:528:DC%2BD3sXpsFOntL8%3D 10.1007/s00726-003-0011-2 14661084
36. AZ Reznick L Packer 1994 Oxidative damage to proteins: spectrophotometric method for carbonyl assay Methods Enzymol 233 357 363 1:CAS:528: DyaK2cXmt1Gnt7k%3D 10.1016/S0076-6879(94)33041-7 8015470
37. E Lissi C Pascual MD Del Castillo 1992 Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis Free Radic Res Commun 17 299 311 1:CAS:528:DyaK3sXmsVCkurs%3D 10.3109/10715769209079523 1483581
38. P Evelson M Travacio M Repetto J Escobar S Llesuy EA Lissi 2001 Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols Arch Biochem Biophys 388 261 266 1:CAS:528: DC%2BD3MXitlOjt7c%3D 10.1006/abbi.2001.2292 11368163
39. SF Leong JB Clark 1984 Regional enzyme development in rat brain. Enzymes associated with glucose utilization Biochem J 218 131 138 1:CAS:528: DyaL2cXhtVSmu7w%3D 6712609
40. A Zhitkovich M Costa 1992 A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo Carcinogenesis 13 1485 1489 1:CAS:528:DyaK38Xls1Ggurw%3D 10.1093/carcin/13.8.1485 1499101
41. OH Lowry NJ Rosebrough A Lewis-Farr RJ Randall 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 275 1:CAS:528: DyaG38XhsVyrsw%3D%3D 14907713
42. ME Rice I Russo-Menna 1998 Differential compartmentalization of brain ascorbate and glutathione between neurons and glia Neuroscience 82 1213 1223 1:CAS:528:DyaK2sXnsF2ks7s%3D 10.1016/S0306-4522(97)00347-3 9466441
43. SL Stvolinski ML Kukley D Dobrota M Matejovicova (Vachova) T Tkac AA Boldyrev 1999 Carnosine: an endogenous neuroprotector in the ischemic brain Cell Mol Neurobiol 19 45 56 10.1023/A:1006960407008
44. P Coyle JC Philcox AM Rofe 2002 Metallothionein: the multipurpose protein Cell Mol Life Sci 59 627 647 1:CAS:528:DC%2BD38XjtlWmtbs%3D 10.1007/s00018-002-8454-2 12022471
45. A Boldyrev E Bulygina T Leinsoo I Petrushanko S Tsubone H Abe 2004 Protection of neuronal cells against reactive oxygen species by carnosine and related compounds Comp Biochem Physiol 137 81 88 10.1016/j.cbpc.2003.10.008
46. LR Guelman RML Pagotto CG Di Toro LM Zieher 2004 Deferoxamine antioxidant activity on cerebellar granule cells γ-irradiated in vitro Neurotoxicol Teratol 26 477 483 1:CAS:528:DC%2BD2cXjsVelt74%3D 10.1016/j.ntt.2004.02.001 15113608
47. V Vassiliev ZL Harris P Zatta 2005 Ceruloplasmin in neurodegenerative diseases Brain Res Rev 49 633 640 1:CAS:528:DC%2BD2MXhtFOhsbrE 10.1016/j.brainresrev.2005.03.003 16269323
48. B Halliwell 2006 Oxidative stress and neurodegeneration: where are we now? J Neurochem 97 1634 1658 1:CAS:528:DC%2BD28Xnt1Ons7g%3D 10.1111/j.1471-4159.2006.03907.x 16805774
49. VN Anisimov IG Popovich MA Zabezhinski SV Anisimov GM Vesnushkin IA Vinogradova 2006 Melatonin as antioxidant, geroprotector and anticarcinogen Biochim Biophys Acta 1757 573 589 1:CAS:528:DC%2BD28Xmsl2jt7k%3D 10.1016/j.bbabio.2006.03.012 16678784
50. S Jimenez-Jorge JM Guerrero A Jimenez-Caliani MC Naranjo PJ Lardone A Carrillo-Vico C Osuna P Molinero 2007 Evidence for melatonin synthesis in the rat brain during development J Pineal Res 42 240 246 1:CAS:528: DC%2BD2sXltFCntbY%3D 10.1111/j.1600-079X.2006.00411.x 17349021
51. E Carpenè G Andreani G Isani 2007 Metallothionein functions and structural characteristics J Trace Elem Med Biol 21 35 39 10.1016/j.jtemb.2007. 09.011 18039494
52. S Bharath BC Cochran M Hsu J Liu BN Ames JK Andersen 2002 Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy Neurotoxicology 23 479 486 1:CAS:528:DC%2BD38XnvVGrtLw%3D 10.1016/S0161-813X(02)00035-9
53. JH Suh SV Shenvi BM Dixon H Liu AK Jaiswal R Liu TM Hagen 2004 Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid Proc Natl Acad Sci USA 101 3381 3386 1:CAS:528:DC%2BD2cXisFWms7s%3D 10.1073/pnas.0400282101 14985508
54. BC Scott OI Aruoma PJ Evans C O'Neill A van der Vliet CE Cross H Trtschler B Halliwell 1994 Lipoic and dihydrolipoic acids as antioxidants: a critical evaluation Free Radic Res 20 119 133 1:CAS:528:DyaK2cXkslersrY%3D 10.3109/10715769409147509 7516789
55. T Fujita H Katsukawa E Yodoya M Wada A Shimada N Okada A Yamamoto V Ganapathy 2005 Transport characteristics of N-acetyl-l-aspartate in rat astrocytes: involvement of sodium-coupled high-affinity carboxylate transporter NaC3/NaDC3-mediated transport system J Neurochem 93 706 714 1:CAS:528: DC%2BD2MXktFKgurk%3D 10.1111/j.1471-4159.2005.03067.x 15836629
56. RL George W Huang HA Naggar SB Smith V Ganapathy 2004 Transport of N-acetylaspartate via murine sodium/dicarboxylate cotransporter NaDC3 and expression of this transporter and aspartoacylase II in ocular tissues in mouse Biochim Biophys Acta 1690 63 69 1:CAS:528:DC%2BD2cXntFWqs70%3D 15337171
57. W Huang H Wang R Kekuda Y Fei A Friedrich J Wang SJ Conway RS Cameron FH Leibach V Ganapathy 2000 Transport of N-acetylaspartate by the Na1-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain J Pharmacol Exp Ther 295 392 403 1:CAS:528:DC%2BD3cXnt1yns7s%3D 10992006